BIOL 3051 Chapter Notes - Chapter 10.1: Selective Estrogen Receptor Modulator, Acute-Phase Protein, Chronic Kidney Disease
24 Apr 2020
School
Department
Course
Professor
Document Summary
Before starting therapy, patients must have adequate dietary calcium and vitamin d: need 1200 mg daily of calcium. 1000mg/day) in divided doses at meal time (total has to be. Calcium carbonate 200, 500, 600mg elemental calcium/tablet. Calcium citrate 300, 500, 600mg elemental calcium/tablet: calcium causes constipation, hypercalcemia (may be related to increase cardiac activity, need 800-2000 iu vitamin d daily, difficult to achieve with diet alone, so supplementation may be required, options: Since raloxifene only prevents against vertebral fractures, it is less effective than bisphosphonates, denosumab, and hormone therapy. Patient is at a __mild/moderate/high__ risk of op secondary to _[name of medication]_ and requires anti-sorptive therapy. Preserve or enhance bone mass and strength while receiving therapy. Prevent fractures, disability and loss of independence while receiving therapy. Increase or maintain vitamin d and calcium at normal levels while receiving therapy. Reduce future falls and fractures while receiving therapy. Prevent further complications of op while receiving therapy.
